2024

1. Meyer, A., Miranda, S., Drouin, J., Weill, A., Carbonnel, F., & Dray-Spira, R. (2024). Safety of vedolizumab and ustekinumab compared with anti-TNF in pregnant women with inflammatory bowel disease. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2023.12.029

2. Swital, M., Drouin, J., Miranda, S., Bakchine, S., Botton, J., & Dray-Spira, R. (2024). Use of multiple sclerosis disease-modifying therapies during pregnancy in France : Nationwide study between 2010 and 2021. Multiple Sclerosis Journal, 13524585231223395. https://doi.org/10.1177/13524585231223395

3. Vegas, L. P., Drouin, J., Weill, A., & Dray-Spira, R. (2024). Pregnancy outcomes in women with rheumatoid arthritis : An 11-year French nationwide study. RMD Open, 10(1), e003762. https://doi.org/10.1136/rmdopen-2023-003762

4. Jourdain, H., Hoisnard, L., Sbidian, E., & Zureik, M. (2024). Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases : An observational study on the French National Health Data System. RMD Open, 10(1), e003531. https://doi.org/10.1136/rmdopen-2023-003531

5. Roland, N., Neumann, A., Haszard, L., Duranteau, L., Froelich, S., Zureik, M., & Weill, A. (2024). Use of progestogens and the risk of intracranial meningioma : National case-control study. BMJ, 384, e078078. https://doi.org/10.1136/bmj-2023-078078

6. Rios, P., Herlemont, P., Fauque, P., Lacour, B., Jouannet, P., Weill, A., Zureik, M., Clavel, J., & Dray-Spira, R. (2024). Medically Assisted Reproduction and Risk of Cancer Among Offspring. JAMA Network Open, 7(5), e249429. https://doi.org/10.1001/jamanetworkopen.2024.9429

7. Hoisnard, L., Meyer, A., Dray-Spira, R., Weill, A., Zureik, M., & Sbidian, E. (2024). Risk of gastrointestinal perforation in patients with rheumatic diseases exposed to janus kinase inhibitors versus adalimumab : Nationwide cohort study. Arthritis & Rheumatology, n/a(n/a). https://doi.org/10.1002/art.42862

8. Blangis, F., Drouin, J., Launay, E., Miranda, S., Zureik, M., Cohen, J. F., Weill, A., Dray-Spira, R., & Chalumeau, M. (2024). Maternal, prenatal and postnatal risk factors for early child physical abuse : A French nationwide cohort study. The Lancet Regional Health – Europe, 0(0). https://doi.org/10.1016/j.lanepe.2024.100921

9. Turpin, A., Semenzato, L., Stephane, S. L. V., Jabagi, M.-J., Bouillon, K., Drouin, J., Bertrand, M., Kanagaratnam, L., Weill, A., Dray-Spira, R., Zureik, M., & Botton, J. (2024). Risk factors for COVID-19 hospitalisation after booster vaccination during the Omicron period : A French nationwide cohort study. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2024.05.007

10. Nguyen, P., Roland, N., Neumann, A., Hoisnard, L., Passeri, T., Duranteau, L., Coste, J., Froelich, S., Zureik, M., & Weill, A. (2024). Prolonged use of nomegestrol acetate and risk of intracranial meningioma : A population-based cohort study. The Lancet Regional Health – Europe, 42, 100928. https://doi.org/10.1016/j.lanepe.2024.100928

11. Maillard, O., Bun, R., Laanani, M., Verga-Gérard, A., Leroy, T., Gault, N., Estellat, C., Noize, P., Kaguelidou, F., Sommet, A., Lapeyre-Mestre, M., Fourrier-Réglat, A., Weill, A., Quantin, C., & Tubach, F. (2024). Use of the French National Health Data System (SNDS) in pharmacoepidemiology : A systematic review in its maturation phase. Therapies. https://doi.org/10.1016/j.therap.2024.05.003

12. Jourdain, H., Mansouri, I., Di Meglio, A., Zureik, M., & Haddy, N. (2024). Utilization and safety of trastuzumab emtansine (T-DM1) : A nationwide population-based study using the French National Health Data System. ESMO Real World Data and Digital Oncology, 4, 100045. https://doi.org/10.1016/j.esmorw.2024.100045

13. Semenzato, L., Le Vu, S., Botton, J., Bertrand, M., Jabagi, M.-J., Drouin, J., Cuenot, F., Zores, F., Dray-Spira, R., Weill, A., & Zureik, M. (2024). Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies. JAMA. https://doi.org/10.1001/jama.2024.16380

14. Botton, J., Bertrand, M., Jabagi, M.-J., Duranteau, L., Bouillon, K., Drouin, J., Semenzato, L., Le Vu, S., Weill, A., Zureik, M., & Dray-Spira, R. (2024). Risk of heavy menstrual bleeding following COVID-19 vaccination : A nationwide case-control study. Vaccine, 42(24), 126252. https://doi.org/10.1016/j.vaccine.2024.126252

15. Le Vu, S., Bertrand, M., Semenzato, L., Jabagi, M.-J., Botton, J., Drouin, J., Weill, A., Dray-Spira, R., & Zureik, M. (2024). Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis. Nature Communications, 15(1), 7745. https://doi.org/10.1038/s41467-024-52038-6

16. Jourdain, H., Albin, N., Monard, A., Desplas, D., Zureik, M., & Haddy, N. (2024). Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric Cancer in a Real-World Setting : A Nationwide Cohort Study. Clinical and Translational Gastroenterology, 10.14309/ctg.0000000000000773. https://doi.org/10.14309/ctg.0000000000000773

17. Roland, N., Nguyen, P., Neumann, A., Hoisnard, L., Passeri, T., Duranteau, L., Coste, J., Froelich, S., Zureik, M., & Weill, A. (2024). Prolonged use of chlormadinone acetate and risk of intracranial meningioma : A population-based cohort study. European Journal of Neurology, n/a(n/a), e16505. https://doi.org/10.1111/ene.16505

2023

6. Billioti de Gage, S., Jourdain, H., Desplas, D., & Dray-Spira, R. (2023). Roll-out and effectiveness of HIV pre-exposure prophylaxis in France : An overview. Therapies. https://doi.org/10.1016/j.therap.2023.02.010

7. Jabagi, M.-J., Bertrand, M., Botton, J., Le Vu, S., Weill, A., Dray-Spira, R., & Zureik, M. (2023). Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMc2302134

8. Laanani, M., Weill, A., Jollant, F., Zureik, M., & Dray-Spira, R. (2023). Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia : Nationwide cohort study. Scientific Reports, 13(1), Article 1. https://doi.org/10.1038/s41598-023-32356-3

9. Wang, H., Molina, J.-M., Dray-Spira, R., Schmidt, A. J., Hickson, F., van de Vijver, D., & Jonas, K. J. (2023). Spatio-temporal changes in pre-exposure prophylaxis uptake among MSM in mainland France between 2016 and 2021 : A Bayesian small area approach with MSM population estimation. Journal of the International AIDS Society, 26(5), e26089. https://doi.org/10.1002/jia2.26089

10. Dugerdil, A., Semenzato, L., Weill, A., Zureik, M., & Flahault, A. (2023). Severe SARS-CoV-2 infection as a marker of undiagnosed cancer : A population-based study. Scientific Reports, 13(1), Article 1. https://doi.org/10.1038/s41598-023-36013-7

11. Lassalle, M., Zureik, M. and Dray-Spira, R. (2023) ‘Proton Pump Inhibitor Use and Risk of Serious Infections in Young Children’, JAMA Pediatrics [Preprint]. Available at: https://doi.org/10.1001/jamapediatrics.2023.2900.

12. Marcombes, C. et al. (2023) ‘Persistence of second-line biologics in psoriasis after first-line biologic failure: a nationwide cohort study from the French health insurance database (SNDS)’, British Journal of Dermatology, p. ljad248. Available at: https://doi.org/10.1093/bjd/ljad248.

13. Tran, A., Zureik, M., Sibiude, J., Drouin, J., Miranda, S., Weill, A., Dray-Spira, R., Duval, X., & Tubiana, S. (2023). Prevalence and associated factors of antibiotic exposure during pregnancy in a large French population-based study during the 2010–19 period. Journal of Antimicrobial Chemotherapy, dkad266. https://doi.org/10.1093/jac/dkad266

14. Semenzato, L., Botton, J., Le Vu, S., Jabagi, M.-J., Cuenot, F., Drouin, J., Dray-Spira, R., Weill, A., & Zureik, M. (2023). Protection of Covid-19 vaccination against hospitalisation during the era of Omicron BA.4 and BA.5 predominance : A nationwide case-control study based on the French National Health Data System. Open Forum Infectious Diseases, ofad460. https://doi.org/10.1093/ofid/ofad460

15. Vu, S. L., Bertrand, M., Botton, J., Jabagi, M.-J., Drouin, J., Semenzato, L., Weill, A., Dray-Spira, R., & Zureik, M. (2023). Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines : A Nationwide Self-controlled Case Series Study. Neurology. https://doi.org/10.1212/WNL.0000000000207847

16. Kolla, E., Weill, A., Zaidan, M., De Martin, E., Colin De Verdiere, S., Semenzato, L., Zureik, M., & Grimaldi, L. (2023). COVID-19 Hospitalization in Solid Organ Transplant Recipients on Immunosuppressive Therapy. JAMA Network Open, 6(11), e2342006. https://doi.org/10.1001/jamanetworkopen.2023.42006

17. Drusch, S., Neumann, A., Michelon, H., Pépin, M., Zureik, M., & Herr, M. (2023). Do Proton Pump Inhibitors Reduce Upper Gastrointestinal Bleeding in Older Patients with Atrial Fibrillation Treated with Oral Anticoagulants? A Nationwide Cohort Study in France. Drugs & Aging. https://doi.org/10.1007/s40266-023-01085-7

2022

1. Billioti de Gage, S., Bertrand, M., Grimaldi, S., & Zureik, M. (2022). Risk of Myocardial Infarction, Stroke, or Death in New Users of Intravitreal Aflibercept Versus Ranibizumab : A Nationwide Cohort Study. Ophthalmology and Therapy, 11, 587‑602. https://doi.org/10.1007/s40123-021-00451-1

2. Billioti de Gage, S., Desplas, D., & Dray-Spira, R. (2022). Roll-out of HIV pre-exposure prophylaxis use in France : A nationwide observational study from 2016 to 2021. The Lancet Regional Health – Europe, 22, 100486. https://doi.org/10.1016/j.lanepe.2022.100486

3. Botton, J., Dray-Spira, R., Baricault, B., Drouin, J., Bertrand, M., Jabagi, M.-J., Weill, A., & Zureik, M. (2022). Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines. Vaccine, 40, 414‑417. https://doi.org/10.1016/j.vaccine.2021.12.009

4. Botton, J., Jabagi, M. J., Bertrand, M., Baricault, B., Drouin, J., Le Vu, S., Weill, A., Farrington, P., Zureik, M., & Dray-Spira, R. (2022). Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France. Annals of Internal Medicine. https://doi.org/10.7326/M22-0988

5. Botton, J., Semenzato, L., Dupouy, J., Dray-Spira, R., Weill, A., Saint-Lary, O., & Zureik, M. (2022). No association of low-dose aspirin with severe COVID-19 in France : A cohort of 31.1 million people without cardiovascular disease. Research and Practice in Thrombosis and Haemostasis, 6(4), e12743. https://doi.org/10.1002/rth2.12743

6. Botton, J., Semenzato, L., Jabagi, M.-J., Baricault, B., Weill, A., Dray-Spira, R., & Zureik, M. (2022). Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations. JAMA Network Open, 5(3), e220868. https://doi.org/10.1001/jamanetworkopen.2022.0868

7. Bouillon, K., Baricault, B., Botton, J., Jabagi, J., Bertrand, M., Semenzato, L., Vu, S. L., Drouin, J., Dray, R., Weill, A., & Zureik, M. (2022). Effectiveness of BNT162b2, mRNA-­1273, and ChAdOx1-­S vaccines against severe covid-­19 outcomes in a nationwide mass vaccination setting : Cohort study. BMJ Medicine. https://doi.org/10.1136/bmjmed-2021-000104

8. Bouillon, K., Baricault, B., Semenzato, L., Botton, J., Bertrand, M., Drouin, J., Dray‐Spira, R., Weill, A., & Zureik, M. (2022). Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID‐19 : A Nationwide Matched Population‐Based Cohort Study. Journal of the American Heart Association, e023357. https://doi.org/10.1161/JAHA.121.023357

9. Dufour, E., Baheux, C., & Zureik, M. (2022). Routine surgeries during the COVID-19 pandemic : A French nationwide cohort study. Annals of Medicine and Surgery, 77, 103721. https://doi.org/10.1016/j.amsu.2022.103721

10. Ghebremichael-Weldeselassie, Y., Jabagi, M. J., Botton, J., Bertrand, M., Baricault, B., Drouin, J., Weill, A., Zureik, M., Dray-Spira, R., & Farrington, P. (2022). A modified self-controlled case series method for event-dependent exposures and high event-related mortality, with application to COVID-19 vaccine safety. Statistics in Medicine, n/a(n/a). https://doi.org/10.1002/sim.9325

11. Hoisnard, L., Laanani, M., Passeri, T., Duranteau, L., Coste, J., Zureik, M., Froelich, S., & Weill, A. (2022). Risk of intracranial meningioma with three potent progestogens : A population-based case-control study. European Journal of Neurology. https://doi.org/10.1111/ene.15423

12. Jabagi, M. J., Botton, J., Bertrand, M., Weill, A., Farrington, P., Zureik, M., & Dray-Spira, R. (2022). Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older. JAMA, 327(1), 80‑82. https://doi.org/10.1001/jama.2021.21699

13. Jourdain, H., de Gage, S. B., Desplas, D., & Dray-Spira, R. (2022). Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France : A nested case-control study. The Lancet Public Health, 7(6), e529‑e536. https://doi.org/10.1016/S2468-2667(22)00106-2

14. Lassalle, M., Tri, T. L., Afchain, P., Camus, M., Kirchgesner, J., Zureik, M., & Dray-Spira, R. (2022). Use of Proton Pump Inhibitors and Risk of Pancreatic Cancer : A Nationwide Case-Control Study Based on the French National Health Data System (SNDS). Cancer Epidemiology, Biomarkers & Prevention, 31(3), 662‑669. https://doi.org/10.1158/1055-9965.EPI-21-0786

15. Le Vu, S., Bertrand, M., Jabagi, M.-J., Botton, J., Drouin, J., Baricault, B., Weill, A., Dray-Spira, R., & Zureik, M. (2022). Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines. Nature Communications, 13(1), 3633. https://doi.org/10.1038/s41467-022-31401-5

16. Mansouri, I., Raffray, M., Lassalle, M., de Vathaire, F., Fresneau, B., Fayech, C., Lazareth, H., Haddy, N., Bayat, S., & Couchoud, C. (2022). An algorithm for identifying chronic kidney disease in the French national health insurance claims database. Néphrologie & Thérapeutique. https://doi.org/10.1016/j.nephro.2022.03.003

17. Meyer, A., Taine, M., Drouin, J., Weill, A., Carbonnel, F., & Dray-Spira, R. (2022). Serious Infections in Children Born to Mothers With Inflammatory Bowel Disease With In Utero Exposure to Thiopurines and Anti-Tumor Necrosis Factor. Clinical Gastroenterology and Hepatology, 20(6), 1269-1281.e9. https://doi.org/10.1016/j.cgh.2021.07.028

18. Penso, L., Bergqvist, C., Meyer, A., Herlemont, P., Weill, A., Zureik, M., Dray-Spira, R., & Sbidian, E. (2022). Risk of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis initiating interleukin 17 inhibitors : A nationwide population-based study using the French national health data system. Arthritis & Rheumatology, 74(2), 244‑252. https://doi.org/10.1002/art.41923

19. Pina Vegas, L., Penso, L., Claudepierre, P., & Sbidian, E. (2022). Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database. JAMA Dermatology, 158(5), 513‑522. https://doi.org/10.1001/jamadermatol.2022.0364

20. Plueschke, K., Flynn, R., Hedenmalm, K., Deli, A.-C., Maciá-Martinez, M.-A., García-Poza, P., Olsen, D., Nguyen, P., & Quinten, C. (2022). Prescribing Patterns of Codeine and Alternative Medicines in Children in Europe. Drug Safety. https://doi.org/10.1007/s40264-022-01214-y

21. Roland, N., Baricault, B., Dray-Spira, R., Weill, A., Duranteau, L., & Zureik, M. (2022). Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019 : A national observational population-based study. International Journal of Gynecology & Obstetrics, n/a(n/a). https://doi.org/10.1002/ijgo.14438

22. Roland, N., Drouin, J., Desplas, D., Duranteau, L., Cuenot, F., Dray-Spira, R., Weill, A., & Zureik, M. (2022). Impact of Coronavirus Disease 2019 (COVID-19) On Contraception Use in 2020 and up until the end of April 2021 in France. Contraception, 108, 50‑55. https://doi.org/10.1016/j.contraception.2021.12.002

23. Sbidian, E., Penso, L., & Meyer, A. (2022). Reply : Comment on: Risk of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis initiating interleukin 17 inhibitors. Arthritis & Rheumatology, 74(3), 547‑548. https://doi.org/10.1002/art.41962

24. Semenzato, L., Botton, J., Drouin, J., Baricault, B., Bertrand, M., Jabagi, M.-J., Cuenot, F., Vu, S. L., Dray-Spira, R., Weill, A., & Zureik, M. (2022). Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule : A cohort study of 28 million people in France. The Lancet Regional Health – Europe, 19, 100441. https://doi.org/10.1016/j.lanepe.2022.100441

25. Taine, M., Offredo, L., Weill, A., Dray-Spira, R., Zureik, M., & Chalumeau, M. (2022). Pediatric Outpatient Prescriptions in Countries With Advanced Economies in the 21st Century : A Systematic Review. JAMA Network Open, 5(4), e225964. https://doi.org/10.1001/jamanetworkopen.2022.5964

26. Vabre, C., Zelmat, Y., Gauthier, M., Pajiep, M., Conte, C., Lapeyre-Mestre, M., Dray-Spira, R., Zureik, M., & Despas, F. (2022). Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia : Analysis of anticancer treatment trajectories—A French population-based study using the French national health data system. American Journal of Hematology, 97(8), E307‑E309. https://doi.org/10.1002/ajh.26621

27. Semenzato, L., Botton, J., Baricault, B., Deloumeaux, J., Joachim, C., Sylvestre, E., Dray-Spira, R., Weill, A., & Zureik, M. (2022). Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories : A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System. PLOS ONE, 17(9), e0274309. https://doi.org/10.1371/journal.pone.0274309

28. Meyer, A., Rios, P., Drouin, J., Weill, A., Carbonnel, F., & Dray-Spira, R. (2022). Maternal exposure to anti-TNF or thiopurines for IBD does not increase risk of early-life malignancy in children. Clinical Gastroenterology and Hepatology, 0(0). https://doi.org/10.1016/j.cgh.2022.08.028

29. Pina-Vegas, L., Drouin, J., Dray-Spira, R., & Weill, A. (2022). Prevalence, mortality, and treatment of patients with rheumatoid arthritis : A cohort study of the French Nation Health Data System, 2010-2019. Joint Bone Spine. https://doi.org/10.1016/j.jbspin.2022.105460

30. Meyer, A., Neumann, A., Drouin, J., Weill, A., Carbonnel, F., & Dray-Spira, R. (2022). Benefits and Risks Associated With Continuation of Anti–Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease. Annals of Internal Medicine. https://doi.org/10.7326/M22-0819

31. Hoisnard, L., Vegas, L. P., Dray-Spira, R., Weill, A., Zureik, M., & Sbidian, E. (2022). Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab : A nationwide cohort study. Annals of the Rheumatic Diseases. https://doi.org/10.1136/ard-2022-222824

32. Jourdain, H., Hoisnard, L., Sbidian, E., & Zureik, M. (2022). TNF-alpha inhibitors biosimilar use in France : A nationwide population-based study using the French National Health Data System. Scientific Reports, 12(1), Art. 1. https://doi.org/10.1038/s41598-022-24050-7

33. Kolla, E., Weill, A., Desplas, D., Semenzato, L., Zureik, M., & Grimaldi, L. (2022). Does Measles,
Mumps, and Rubella (MMR) Vaccination Protect against COVID-19 Outcomes : A Nationwide
Cohort Study. Vaccines, 10(11), Art. 11. https://doi.org/10.3390/vaccines10111938

34. Drusch, S., Le Tri, T., Ankri, J., Michelon, H., Zureik, M., & Herr, M. (2022). Potentially inappropriate medications in nursing homes and the community older adults using the French health insurance databases. Pharmacoepidemiology and Drug Safety, n/a(n/a). https://doi.org/10.1002/pds.5575

35. Tubiana, S., Sibiude, J., Herlemont, P., Drouin, J., Picone, O., Duval, X., Weill, A., Zureik, M., & Dray-Spira, R. (2022). Trends in anti-infective use during pregnancy in France between 2010 and 2019 : A nationwide population-based study. British Journal of Clinical Pharmacology, n/a(n/a). https://doi.org/10.1111/bcp.15638

2021
1. Billioti de Gage, S., Bertrand, M., Grimaldi, S., & Zureik, M. (2021). Intravitreal anti-VEGF use in France : A cross-sectional and longitudinal Nationwide observational study. Acta Ophthalmologica, n/a(n/a). https://doi.org/10.1111/aos.14929
2. Billioti de Gage, S., Drouin, J., Desplas, D., Cuenot, F., Dray-Spira, R., Weill, A., & Zureik, M. (2021). Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic. JAMA Ophthalmology, 139(2), 240‑242. https://doi.org/10.1001/jamaophthalmol.2020.5594
3. Drusch, S., Le Tri, T., Ankri, J., Zureik, M., & Herr, M. (2021). Decreasing trends in potentially inappropriate medications in older people : A nationwide repeated cross-sectional study. BMC Geriatrics, 21(1), 621. https://doi.org/10.1186/s12877-021-02568-1
4. Grodner, C., Sbidian, E., Weill, A., & Mezzarobba, M. (2021). Epidemiologic study in a real-world analysis of patients with treatment for psoriasis in the French national health insurance database. Journal of the European Academy of Dermatology and Venereology, 35(2), 411‑416. https://doi.org/10.1111/jdv.16566
5. Jabagi, M.-J., Vey, N., Goncalves, A., Tri, T. L., Zureik, M., & Dray‑spira, R. (2021). Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support : A nationwide population-based cohort. International Journal of Cancer, 148(2), 375‑384. https://doi.org/10.1002/ijc.33216
6. Meyer, A., Drouin, J., Weill, A., Carbonnel, F., & Dray-Spira, R. (2021). Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and/or anti-TNF : A French nationwide study 2010–2018. Alimentary Pharmacology & Therapeutics, 54(3), 302‑311. https://doi.org/10.1111/apt.16448
7. Meyer, A., Drouin, J., Zureik, M., Weill, A., & Dray-Spira, R. (2021). Colonoscopy in France during the COVID-19 pandemic. International Journal of Colorectal Disease, 36, 1073‑1075. https://doi.org/10.1007/s00384-020-03816-3
8. Meyer, A., Fermaut, M., Drouin, J., Carbonnel, F., & Weill, A. (2021). Drug use for gastrointestinal symptoms during pregnancy : A French nationwide study 2010–2018. PLOS ONE, 16(1), e0245854. https://doi.org/10.1371/journal.pone.0245854
9. Meyer, A., Semenzato, L., Zureik, M., Weill, A., Carbonnel, F., & Dray-Spira, R. (2021). Risk of severe COVID-19 in patients treated with IBD medications : A French nationwide study. Alimentary Pharmacology & Therapeutics, 54(2), 160‑166. https://doi.org/10.1111/apt.16410
10. Neumann, A., Jabagi, M.-J., & Zureik, M. (2021). Vitamin K antagonists did not increase the risk of myelodysplastic syndrome in a large-scale cohort study. Blood, 138(5), 417‑420. https://doi.org/10.1182/blood.2021010848
11. Penso, L., Dray-Spira, R., Weill, A., Pina Vegas, L., Zureik, M., & Sbidian, E. (2021). Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis. JAMA Dermatology, 157(9), 1056‑1065. https://doi.org/10.1001/jamadermatol.2021.2599
12. Penso, L., Dray‑Spira, R., Weill, A., Zureik, M., & Sbidian, E. (2021). Drop in biological initiation for patients with psoriasis during the COVID-pandemic. British Journal of Dermatology, 185(3), 671‑673. https://doi.org/10.1111/bjd.20406
13. Penso, L., Dray-Spira, R., Weill, A., Zureik, M., & Sbidian, E. (2021). Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic : Cohort study of 1,326,312 patients in France. British Journal of Dermatology, n/a(n/a). https://doi.org/10.1111/bjd.20659
14. Roland, N., Drouin, J., Desplas, D., Cuenot, F., Dray-Spira, R., Weill, A., & Zureik, M. (2021). Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France. Obstetrics & Gynecology, 137(3), 415‑417. https://doi.org/10.1097/AOG.0000000000004281
15. Semenzato, L., Botton, J., Drouin, J., Cuenot, F., Dray-Spira, R., Weill, A., & Zureik, M. (2021). Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France : A cohort study of 66 million people. The Lancet Regional Health – Europe, 8, 100158. https://doi.org/10.1016/j.lanepe.2021.100158
16. Semenzato Laura, Botton Jérémie, Drouin Jérôme, Baricault Bérangère, Vabre Clémentine, Cuenot François, Penso Laetitia, Herlemont Philippe, Sbidian Emilie, Weill Alain, Dray-Spira Rosemary, & Zureik Mahmoud. (2021). Antihypertensive Drugs and COVID-19 Risk. Hypertension, 77(3), 833‑842. https://doi.org/10.1161/HYPERTENSIONAHA.120.16314
17. Taine, M., Offredo, L., Dray-Spira, R., Weill, A., Chalumeau, M., & Zureik, M. (2021). Paediatric outpatient prescriptions in France between 2010 and 2019 : A nationwide population-based study: Paediatric outpatient prescriptions in France, 2010 to 2019. The Lancet Regional Health – Europe, 7, 100129. https://doi.org/10.1016/j.lanepe.2021.100129
18. Taine, M., Offredo, L., Drouin, J., Toubiana, J., Weill, A., Zureik, M., & Dray-Spira, R. (2021). Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020. Frontiers in Pediatrics, 9. https://doi.org/10.3389/fped.2021.666848
19. Voormolen, E. H. J., Champagne, P. O., Roca, E., Giammattei, L., Passeri, T., di Russo, P., Sanchez, M. M., Bernat, A. L., Yoldjian, I., Fontanel, S., Weill, A., Mandonnet, E., & Froelich, S. (2021). Intracranial Meningiomas Decrease in Volume on Magnetic Resonance Imaging After Discontinuing Progestin. Neurosurgery, 89(2), 308‑314. https://doi.org/10.1093/neuros/nyab175
20. Weill, A., Nguyen, P., Labidi, M., Cadier, B., Passeri, T., Duranteau, L., Bernat, A.-L., Yoldjian, I., Fontanel, S., Froelich, S., & Coste, J. (2021). Use of high dose cyproterone acetate and risk of intracranial meningioma in women : Cohort study. BMJ, 372, n37. https://doi.org/10.1136/bmj.n37

2020

1. Bergqvist, C., Mezzarobba, M., Weill, A., & Sbidian, E. (2020). Persistence of treatment with conventional systemic agents for patients with psoriasis : A real-world analysis of 73,168 new-users from the French National Health Insurance database (SNDS). British Journal of Dermatology, 182(6), 1483‑1484. https://doi.org/10.1111/bjd.18734
2. Blotière, P.-O., Miranda, S., Weill, A., Mikaeloff, Y., Peyre, H., Ramus, F., Mahmoud, Z., Coste, J., & Dray-Spira, R. (2020). Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy : A French nationwide population-based cohort study. BMJ Open, 10(6), e034829. https://doi.org/10.1136/bmjopen-2019-034829
3. Bouyer, B., Leroy, F., Rudant, J., Weill, A., & Coste, J. (2020). Burden of fractures in France : Incidence and severity by age, gender, and site in 2016. International Orthopaedics, 44, 947‑955. https://doi.org/10.1007/s00264-020-04492-2
4. Coste, J., Blotiere, P.-O., Miranda, S., Mikaeloff, Y., Peyre, H., Ramus, F., Zureik, M., Weill, A., & Dray-Spira, R. (2020). Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs : A nationwide cohort study in France. Scientific Reports, 10(1), 17362. https://doi.org/10.1038/s41598-020-74409-x
5. Grave, C., Boucheron, P., Rudant, J., Mikaeloff, Y., Tubert-Bitter, P., Escolano, S., Hocine, M. N., Coste, J., & Weill, A. (2020). Seasonal influenza vaccine and Guillain-Barré syndrome : A self-controlled case series study. Neurology, 94(20), e2168‑e2179. https://doi.org/10.1212/WNL.0000000000009180
6. Grave, C., Tribouilloy, C., Juilliere, Y., Tuppin, P., Weill, A., Gabet, A., & Olié, V. (2020a). Hospitalisations pour valvulopathie en France : Caractéristiques des patients et évolution 2006-2016. Bulletin Epidémiologique Hebdomadaire, 4, 70‑79.
7. Grave, C., Tribouilloy, C., Juilliere, Y., Tuppin, P., Weill, A., Gabet, A., & Olié, V. (2020b). Mortalité avec valvulopathie en France : Caractéristiques des patients et évolution 2000-2014. Bulletin Epidémiologique Hebdomadaire, 4, 80‑88.
8. Grodner, C., Mezzarobba, M., Weill, A., & Sbidian, E. (2020). Evolution of topical steroids consumption before and after initiation of systemic treatment in psoriasis. Epidemiologic study in a real-world analysis of the French national health insurance database. Journal of the European Academy of Dermatology and Venereology, 34, e259‑e262. https://doi.org/10.1111/jdv.16238
9. Lanani, M., Weill, A., Carbonnel, F., Pouchot, J., & Coste, J. (2020). Incidence of and Risk Factors for Systemic Adverse Events After Screening or Primary Diagnostic Colonoscopy : A Nationwide Cohort Study. The American Journal of Gastroenterology, 115(4), 537‑547. https://doi.org/10.14309/ajg.0000000000000574
10. Lassalle, M., Le Tri, T., Bardou, M., Biour, M., Kirchgesner, J., Rouby, F., Dumarcet, N., Zureik, M., & Dray-Spira, R. (2020). Use of Proton Pump Inhibitors in Adults in France : A Nationwide Drug Utilization Study. European Journal of Clinical Pharmacology, 76, 449‑457. https://doi.org/10.1007/s00228-019-02810-1
11. Maura, G., Bardou, M., Billionnet, C., Weill, A., Drouin, J., & Neumann, A. (2020). Oral anticoagulants and risk of acute liver injury in patients with nonvalvular atrial fibrillation : A propensity-weighted nationwide cohort study. Scientific Reports, 10(1), 11624. https://doi.org/10.1038/s41598-020-68304-8

12. Meyer, A., Drouin, J., Weill, A., Carbonnel, F., & Dray‑Spira, R. (2020). Pregnancy in women with inflammatory bowel disease : A French nationwide study 2010-2018. Alimentary Pharmacology & Therapeutics, 52(9), 1480‑1490. https://doi.org/10.1111/apt.16074
13. Sbidian, E., Penso, L., Herlemont, P., Botton, J., Baricault, B., Semenzato, L., Drouin, J., Weill, A., Dray-Spira, R., & Zureik, M. (2020). Comment on ‘Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19’ by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19 : A nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-218647

2019

1. Blotiere, P.-O., Raguideau, F., Weill, A., Elefant, E., Perthus, I., Goulet, V., Rouget, F., Zureik, M., Coste, J., & Dray-Spira, R. (2019). Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs. Neurology, 93(2), e167‑e180. https://doi.org/10.1212/WNL.0000000000007696
2. Bouyer, B., Zureik, M., Dray-Spira, R., Weill, A., & Coste, J. (2019). Le Système National des Données de Santé : Description et application dans le champ de l’orthopédie. Revue de Chirurgie Orthopédique et Traumatologique, 105(8), 961‑966. https://doi.org/10.1016/j.rcot.2019.10.021
3. Coste, J., Bertagna, X., & Zureik, M. (2019). Comment on : « Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients? » Clinical Pharmacokinetics, 58(7), 965‑966. https://doi.org/10.1007/s40262-019-00779-9
4. Coste, J., Bertagna, X., Zureik, M., Nicolas, P., Ramez, P., Hill, C., & Schlumberger, M. (2019). [Are the two formulas of Levothyrox bioequivalent?]. La Revue Du Praticien, 69(8), 831‑837.
5. Coste, J., Karras, A., Rudnichi, A., Dray-Spira, R., Pouchot, J., Giral, P., & Zureik, M. (2019). Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury. Pharmacoepidemiology and Drug Safety, 28, 1583‑1590. https://doi.org/10.1002/pds.4898
6. Giral, P., Neumann, A., Weill, A., & Coste, J. (2019). Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years : A nationwide population-based cohort study in France. European Heart Journal, 40(43), 3516‑3525. https://doi.org/10.1093/eurheartj/ehz458
7. Jabagi, M. J., Goncalves, A., Vey, N., Le Tri, T., Zureik, M., & Dray-Spira, R. (2019). Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast Cancer. Cancers, 11(10), 1463. https://doi.org/10.3390/cancers11101463
8. Jabagi, M.-J., Vey, N., Goncalves, A., Le Tri, T., Zureik, M., & Dray-Spira, R. (2019). Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France. JAMA Netw Open, 2(1), e187147. https://doi.org/10.1001/jamanetworkopen.2018.7147
9. Laanani, M., Coste, J., Blotiere, P.-O., Carbonnel, F., & Weill, A. (2019). Patient, Procedure, and Endoscopist Risk Factors for Perforation, Bleeding, and Splenic Injury After Colonoscopies. Clin Gastroenterol Hepatol, 17(4), 719-727 e13. https://doi.org/10.1016/j.cgh.2018.08.005
10. Maura, G., Billionnet, C., Drouin, J., Weill, A., Neumann, A., & Pariente, A. (2019). Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants : Findings from the French healthcare databases, 2011–2016. BMJ Open, 9(4), e026645. https://doi.org/10.1136/bmjopen-2018-026645
11. Meyer, A., Rudant, J., Drouin, J., Coste, J., Carbonnel, F., & Weill, A. (2019). The effectiveness and safety of infliximab compared with biosimilar CT-P13, in 3112 patients with ulcerative colitis in real-life. Alimentary Pharmacology & Therapeutics, 50(3), 269‑277. https://doi.org/10.1111/apt.15323
12. Meyer, A., Rudant, J., Drouin, J., Weill, A., Carbonnel, F., & Coste, J. (2019). Effectiveness and Safety of Reference Infliximab and Biosimilar in Crohn Disease : A French Equivalence Study. Annals of internal medicine, 170(2), 99‑107. https://doi.org/10.7326/M18-1512
13. Rudant, J., Dupont, A., Mikaeloff, Y., Bolgert, F., Coste, J., & Weill, A. (2019). Author response to Dr. Steiner. Neurology. https://n.neurology.org/content/author-response-dr-steiner

14. Sbidian, E., Billionnet, C., Weill, A., Maura, G., & Mezzarobba, M. (2019). Persistence of apremilast in moderate-to-severe psoriasis. A real-world analysis of 14,147 apremilast- and methotrexate-naive patients in the French national health insurance database. British Journal of Dermatology, 182(3), 690‑697. https://doi.org/10.1111/bjd.18047
15. Sbidian, E., Mezzarobba, M., Weill, A., Coste, J., & Rudant, J. (2019). Persistence of treatment with biologics for patients with psoriasis : A real-world analysis of 16 545 biologic-naive patients from the French National Health Insurance database (SNIIRAM). Br J Dermatol, 180(1), 86‑93. https://doi.org/10.1111/bjd.16809
16. Schapiro-Dufour, E., Tricotel, A., Slama, M. S., Ducimetière, P., Trinh-Duc, A., Sichel, C., Le Tri, T., Galmiche, H., Dray-Spira, R., & Zureik, M. (2019). Major ischaemic and bleeding risks following current drug-eluting stent implantation : Are there differences across current drug-eluting stent types in real life? Archives of Cardiovascular Diseases, 112(8‑9), 469‑484. https://doi.org/10.1016/j.acvd.2019.04.007
17. Tournier, M., Neumann, A., Pambrun, E., Weill, A., Chaffiol, J.-P., Alla, F., Bégaud, B., Maura, G., & Verdoux, H. (2019). Conventional mood stabilizers and/or second-generation antipsychotic drugs in bipolar disorders : A population-based comparison of risk of treatment failure. Journal of Affective Disorders, 257, 412‑420. https://doi.org/10.1016/j.jad.2019.07.054
18. Verma, D., Kumar, R., Pereira, R. S., Karantanou, C., Zanetti, C., Minciacchi, V. R., Fulzele, K., Kunz, K., Hoelper, S., Zia-Chahabi, S., Jabagi, M.-J., Emmerich, J., Dray-Spira, R., Kuhlee, F., Hackmann, K., Schroeck, E., Wenzel, P., Müller, S., Filmann, N., … Krause, D. S. (2019). Vitamin K-antagonism impairs the bone marrow microenvironment and hematopoiesis. Blood, 134(3), 277‑238. https://doi.org/10.1182/blood.2018874214

Note : les publications scientifiques d’avant la création d’EPI-PHARE concernent les membres actuels d’EPI-PHARE avec leur ancienne affiliation (ANSM, CNAM, INSERM…)

2018

1. Azogui-Lévy, S., Dray-Spira, R., Attal, S., Hartemann, A., Anagnostou, F., & Azerad, J. (2018). Factors associated with oral health-related quality of life in patients with diabetes. Australian Dental Journal, 63(2), 163‑169. https://doi.org/10.1111/adj.12577
2. Billioti de Gage, S., Collin, C., Le Tri, T., Pariente, A., Begaud, B., Verdoux, H., Dray-Spira, R., & Zureik, M. (2018). Antidepressants and Hepatotoxicity : A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database. CNS Drugs, 32(7), 673‑684. https://doi.org/10.1007/s40263-018-0537-1
3. Blotiere, P.-O., Weill, A., Dalichampt, M., Billionnet, C., Mezzarobba, M., Raguideau, F., Dray-Spira, R., Zureik, M., Coste, J., & Alla, F. (2018). Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases : An application to antiepileptic drug use in 4.9 million pregnant women in France. Pharmacoepidemiol Drug Saf, 27(7), 763‑770. https://doi.org/10.1002/pds.4556
4. Bouillon, K., Bertrand, M., Bader, G., Lucot, J.-P., Dray-Spira, R., & Zureik, M. (2018). Association of Hysteroscopic vs Laparoscopic Sterilization With Procedural, Gynecological, and Medical Outcomes. JAMA, 319(4), 375‑387. https://doi.org/10.1001/jama.2017.21269
5. Bouyer, B., Rudnichi, A., Dray-Spira, R., Zureik, M., & Coste, J. (2018). Thromboembolic risk after lumbar spine surgery : A cohort study on 325 000 French patients. J Thromb Haemost, 16(8), 1537‑1545. https://doi.org/10.1111/jth.14205

6. Chaignot, C., Zureik, M., Rey, G., Dray-Spira, R., Coste, J., & Weill, A. (2018). Risk of hospitalisation and death related to baclofen for alcohol use disorders : Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France. Pharmacoepidemiol Drug Saf, 27(11), 1239‑1248. https://doi.org/10.1002/pds.4635
7. Coste, J., Billionnet, C., Rudnichi, A., Pouchot, J., Dray-Spira, R., Giral, P., & Zureik, M. (2018). Statins for primary prevention and rhabdomyolysis : A nationwide cohort study in France. Eur J Prev Cardiol, 2047487318776831. https://doi.org/10.1177/2047487318776831
8. de Monteynard, L.-A., Matheron, S., Grabar, S., de Truchis, P., Gilquin, J., Pavie, J., Launay, O., Meynard, J.-L., Khuong-Josses, M.-A., Rey, D., Mahamat, A., Dray-Spira, R., Simon, A., Costagliola, D., Abgrall, S., & FHDH-ANRS CO4. (2018). Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France. PloS One, 13(10), e0205385. https://doi.org/10.1371/journal.pone.0205385
9. Feuillet, P., Hamelin, C., Spire, B., Dray-Spira, R., Lert, F., & ANRS-Vespa2 study group. (2018). Intimate ties of people living with HIV in France resulted both from social status and the experience of being HIV-infected : Results from the ANRS-Vespa2 study, France. AIDS Care, 30(7), 807‑816. https://doi.org/10.1080/09540121.2017.1420136
10. Fiorentino, M., Suzan-Monti, M., Vilotitch, A., Sagaon-Teyssier, L., Dray-Spira, R., Lert, F., Spire, B., & ANRS-VESPA2 Study Group. (2018). Renunciation of health care by people living with HIV in France is still associated with discrimination in health-care services and social insecurity—Results from the ANRS-VESPA2 survey. Antiviral Therapy, 23(5), 443‑450. https://doi.org/10.3851/IMP3220

11. Gosselin, A., Desgrées du Loû, A., Lelièvre, E., Lert, F., Dray-Spira, R., Lydié, N., & Parcours Study Group. (2018). Understanding Settlement Pathways of African Immigrants in France Through a Capability Approach : Do Pre-migratory Characteristics Matter? European Journal of Population = Revue Europeenne De Demographie, 34(5), 849‑871. https://doi.org/10.1007/s10680-017-9463-z
12. Iwuji, C. C., Orne-Gliemann, J., Larmarange, J., Balestre, E., Thiebaut, R., Tanser, F., Okesola, N., Makowa, T., Dreyer, J., Herbst, K., McGrath, N., Bärnighausen, T., Boyer, S., De Oliveira, T., Rekacewicz, C., Bazin, B., Newell, M.-L., Pillay, D., Dabis, F., & ANRS 12249 TasP Study Group. (2018). Universal test and treat and the HIV epidemic in rural South Africa : A phase 4, open-label, community cluster randomised trial. The Lancet. HIV, 5(3), e116‑e125. https://doi.org/10.1016/S2352-3018(17)30205-9
13. Kirchgesner, J., Lemaitre, M., Carrat, F., Zureik, M., Carbonnel, F., & Dray-Spira, R. (2018). Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases. Gastroenterology, 155(2), 337-346 e10. https://doi.org/10.1053/j.gastro.2018.04.012
14. Lassalle, M., Colas, S., Rudnichi, A., Zureik, M., & Dray-Spira, R. (2018). Is There a Cardiotoxicity Associated With Metallic Head Hip Prostheses? A Cohort Study in the French National Health Insurance Databases. Clinical Orthopaedics and Related Research, 476(7), 1441‑1451. https://doi.org/10.1097/01.blo.0000533617.64678.69
15. Lassalle, M., Colas, S., Zureik, M., & Dray-Spira, R. (2018). Reply to the Letter to the Editor : Is There a Cardiotoxicity Associated With Metallic Head Hip Prostheses? A Cohort Study in the French National Health Insurance Databases. Clinical Orthopaedics and Related Research, 476(12), 2462‑2463. https://doi.org/10.1097/CORR.0000000000000525
16. Maura, G., Billionnet, C., Coste, J., Weill, A., Neumann, A., & Pariente, A. (2018). Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants : A Sequence Symmetry Analysis. Drug Saf, 41(9), 881‑897. https://doi.org/10.1007/s40264-018-0668-9
17. Maura, G., Chaignot, C., Weill, A., Alla, F., & Heard, I. (2018). Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France : A nationwide French healthcare database study. European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP), 27(5), 479‑485. https://doi.org/10.1097/CEJ.0000000000000360
18. Neumann, A., Maura, G., Weill, A., Alla, F., & Danchin, N. (2018). Clinical Events After Discontinuation of beta-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction : A Cohort Study on the French Healthcare Databases. Circ Cardiovasc Qual Outcomes, 11(4), e004356. https://doi.org/10.1161/CIRCOUTCOMES.117.004356
19. Raman, S. R., Man, K. K. C., Bahmanyar, S., Berard, A., Bilder, S., Boukhris, T., Bushnell, G., Crystal, S., Furu, K., KaoYang, Y.-H., Karlstad, Ø., Kieler, H., Kubota, K., Lai, E. C.-C., Martikainen, J. E., Maura, G., Moore, N., Montero, D., Nakamura, H., … Wong, I. C. K. (2018). Trends in attention-deficit hyperactivity disorder medication use : A retrospective observational study using population-based databases. The Lancet Psychiatry, 5(10), 824‑835. https://doi.org/10.1016/S2215-0366(18)30293-1
20. Roux, P., Marcellin, F., Ndiaye, K., Suzan-Monti, M., Mayet, A., Duracinsky, M., Briand-Madrid, L., Maradan, G., Mora, M., Préau, M., Verger, P., Carrieri, P., Dray-Spira, R., Spire, B., & ANRS-VESPA2 Study Group. (2018). Posttraumatic Stress Disorder as a Significant Correlate of Voluntary Antiretroviral Treatment Interruption in Adult HIV-Infected Patients Followed up in French Hospitals : Data From the ANRS-VESPA2 National Survey. The Journal of Clinical Psychiatry, 79(3). https://doi.org/10.4088/JCP.17m11659
21. Rudant, J., Dupont, A., Mikaeloff, Y., Bolgert, F., Coste, J., & Weill, A. (2018). Surgery and risk of Guillain-Barre syndrome : A French nationwide epidemiologic study. Neurology, 91(13), e1220‑e1227. https://doi.org/10.1212/WNL.0000000000006246
22. Suzan-Monti, M., Celse, M., Vilotitch, A., Demoulin, B., Dray-Spira, R., Yéni, P., Lert, F., Spire, B., & ANRS VESPA2 study group. (2018). Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey). AIDS and Behavior, 22(10), 3264‑3272. https://doi.org/10.1007/s10461-018-2077-6
23. Vignier, N., Desgrées du Loû, A., Pannetier, J., Ravalihasy, A., Gosselin, A., Lert, F., Lydié, N., Bouchaud, O., Dray Spira, R., & PARCOURS Study Group. (2018). Access to health insurance coverage among sub-Saharan African migrants living in France : Results of the ANRS-PARCOURS study. PloS One, 13(2), e0192916. https://doi.org/10.1371/journal.pone.0192916
24. Vignier, N., Dray Spira, R., Pannetier, J., Ravalihasy, A., Gosselin, A., Lert, F., Lydie, N., Bouchaud, O., Desgrees Du Lou, A., Chauvin, P., & PARCOURS Study Group. (2018). Refusal to provide healthcare to sub-Saharan migrants in France : A comparison according to their HIV and HBV status. European Journal of Public Health, 28(5), 904‑910. https://doi.org/10.1093/eurpub/cky118

2017

1. Billionnet, C., Mitanchez, D., Weill, A., Nizard, J., Alla, F., Hartemann, A., & Jacqueminet, S. (2017). Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia, 60(4), 636‑644. https://doi.org/10.1007/s00125-017-4206-6
2. Boyer, V., Vilotitch, A., Marcellin, F., Demoulin, B., Dray-Spira, R., Spire, B., & ANRS-VESPA2 Study Group. (2017). Self-Reported Bothersome Symptoms Across Different Socioepidemiological Groups of People Living With HIV Attending French Hospitals : Results From the ANRS-VESPA2 Survey. Journal of Pain and Symptom Management, 54(1), 110‑119. https://doi.org/10.1016/j.jpainsymman.2017.03.010
3. Carrieri, M. P., Marcellin, F., Fressard, L., Préau, M., Sagaon-Teyssier, L., Suzan-Monti, M., Guagliardo, V., Mora, M., Roux, P., Dray-Spira, R., Spire, B., & ANRS-VESPA2 Study Group. (2017). Suicide risk in a representative sample of people receiving HIV care : Time to target most-at-risk populations (ANRS VESPA2 French national survey). PloS One, 12(2), e0171645. https://doi.org/10.1371/journal.pone.0171645
4. Colas, S., Allalou, A., Poichotte, A., Piriou, P., Dray-Spira, R., & Zureik, M. (2017). Exchangeable Femoral Neck (Dual-Modular) THA Prostheses Have Poorer Survivorship Than Other Designs : A Nationwide Cohort of 324,108 Patients. Clin Orthop Relat Res, 475(8), 2046‑2059. https://doi.org/10.1007/s11999-017-5260-6
5. Delannoy, A., Rudant, J., Chaignot, C., Bolgert, F., Mikaeloff, Y., & Weill, A. (2017). Guillain-Barré syndrome in France : A nationwide epidemiological analysis based on hospital discharge data (2008-2013). Journal of the Peripheral Nervous System: JPNS, 22(1), 51‑58. https://doi.org/10.1111/jns.12202
6. Feuillet, P., Lert, F., Tron, L., Aubriere, C., Spire, B., Dray-Spira, R., & Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)-VIH: Enquête sur les personnes atteintes (Vespa2) Study Group. (2017). Prevalence of and factors associated with depression among people living with HIV in France. HIV Medicine, 18(6), 383‑394. https://doi.org/10.1111/hiv.12438
7. Fonteneau, L., Meur, N. L., Cohen-Akenine, A., Pessel, C., Brouard, C., Delon, F., Desjeux, G., Durand, J., Kirchgesner, J., Lapidus, N., Lemaitre, M., Tala, S., Thiébaut, A., Watier, L., Rudant, J., & Guillon-Grammatico, L. (2017). Apport des bases médico-administratives en épidémiologie et santé publique des maladies infectieuses. Revue d’Epidémiologie et de Santé Publique, 65(Suppl 4). https://www.em-consulte.com/en/article/1140907
8. Foulon, S., Maura, G., Dalichampt, M., Alla, F., Debouverie, M., Moreau, T., & Weill, A. (2017). Prevalence and mortality of patients with multiple sclerosis in France in 2012 : A study based on French health insurance data. Journal of Neurology, 264(6), 1185‑1192. https://doi.org/10.1007/s00415-017-8513-0
9. Gallini, A., Moisan, F., Maura, G., Carcaillon-Bentata, L., Leray, E., Haesebaert, J., Bruandet, A., Moutengou, E., Luciano, L., Weill, A., Marin, B., & Gardette, V. (2017). [Identification of neurodegenerative diseases in administrative databases in France : A systematic review of the literature]. Revue D’epidemiologie Et De Sante Publique, 65 Suppl 4, S183‑S197. https://doi.org/10.1016/j.respe.2017.01.115
10. Kirchgesner, J., Lemaitre, M., Rudnichi, A., Racine, A., Zureik, M., Carbonnel, F., & Dray-Spira, R. (2017). Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents : Analysis of the French administrative health databases 2009-2014. Aliment Pharmacol Ther, 45(1), 37‑49. https://doi.org/10.1111/apt.13835

11. Le Cossec, C., Colas, S., & Zureik, M. (2017). Relative impact of hospital and surgeon procedure volumes on primary total hip arthroplasty revision : A nationwide cohort study in France. Arthroplast Today, 3(3), 176‑182. https://doi.org/10.1016/j.artd.2017.03.010
12. Lefeuvre, D., Rudant, J., Foulon, S., Alla, F., & Weill, A. (2017). Healthcare expenditure of multiple sclerosis patients in 2013 : A nationwide study based on French health administrative databases: Multiple Sclerosis Journal – Experimental, Translational and Clinical. https://doi.org/10.1177/2055217317730421
13. Lemaitre, M., Kirchgesner, J., Rudnichi, A., Carrat, F., Zureik, M., Carbonnel, F., & Dray-Spira, R. (2017). Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease. JAMA, 318(17), 1679‑1686. https://doi.org/10.1001/jama.2017.16071
14. Limousi, F., Lert, F., Desgrées du Loû, A., Dray-Spira, R., Lydié, N., & PARCOURS Study Group. (2017). Dynamic of HIV-testing after arrival in France for migrants from sub-Saharan Africa : The role of both health and social care systems. PloS One, 12(12), e0188751. https://doi.org/10.1371/journal.pone.0188751
15. Marcellin, F., Suzan-Monti, M., Vilotitch, A., Sagaon-Teyssier, L., Mora, M., Dray-Spira, R., Préau, M., Lert, F., Spire, B., & ANRS VESPA2 Study Group. (2017). Disclosure of HIV Status Beyond Sexual Partners by People Living with HIV in France : A Call for Help? Results from the National Cross-Sectional Survey ANRS-VESPA2. AIDS and Behavior, 21(1), 196‑206. https://doi.org/10.1007/s10461-016-1549-9
16. Maura, G., Chaignot, C., Weill, A., Alla, F., & Heard, I. (2017). Dépistage du cancer du col de l’utérus et actes associés chez les femmes de moins de 25 ans entre 2007 et 2013 en France : Une étude sur les bases de données médico-administratives françaises. Bulletin Epidémiologique Hebdomadaire, 2‑3, 32‑38.
17. Miranda, S., Chaignot, C., Collin, C., Dray-Spira, R., Weill, A., & Zureik, M. (2017). Human papillomavirus vaccination and risk of autoimmune diseases : A large cohort study of over 2million young girls in France. Vaccine, 35(36), 4761‑4768. https://doi.org/10.1016/j.vaccine.2017.06.030
18. Moulin, A., Colas, S., Rudnichi, A., Allalou, A., Heuls, B., Zureik, M., & Dray-Spira, R. (2017, mars 23). Prothèses totales de hanche à surface de frottement métallique et risque de lymphome non hodgkinien. Etude sur les données du SNIIRAM. Colloque Adelf-Emois « Système d’information hospitalier et Epidémiologie », Nancy.
19. Pannetier, J., Gigonzac, V., Lydié, N., Desgrées du Loû, A., & Dray Spira, R. (2017). Timing of chronic hepatitis B diagnosis after migration and its determinants among Sub-Saharan African migrants living in France. PloS One, 12(12), e0189196. https://doi.org/10.1371/journal.pone.0189196
20. Poidvin, A., Weill, A., Ecosse, E., Coste, J., & Carel, J.-C. (2017). Risk of Diabetes Treated in Early Adulthood After Growth Hormone Treatment of Short Stature in Childhood. The Journal of Clinical Endocrinology and Metabolism, 102(4), 1291‑1298. https://doi.org/10.1210/jc.2016-3145
21. Seng, R., Ghislain, M., Girard, P.-M., Cotte, L., Meybeck, A., Raffi, F., Abgrall, S., Yazdanpanah, Y., Goujard, C., Dray-Spira, R., & Meyer, L. (2017). Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives. AIDS (London, England), 31(9), 1323‑1332. https://doi.org/10.1097/QAD.0000000000001482
22. Tron, L., Lert, F., Spire, B., Dray-Spira, R., & Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‑Vespa2 Study Group. (2017). Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France. HIV Medicine, 18(3), 181‑195. https://doi.org/10.1111/hiv.12412
23. Tubiana, S., Blotière, P.-O., Hoen, B., Lesclous, P., Millot, S., Rudant, J., Weill, A., Coste, J., Alla, F., & Duval, X. (2017). Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves : Nationwide population based cohort and a case crossover study. BMJ, 358. https://doi.org/10.1136/bmj.j3776
24. Tuppin, P., Rudant, J., Constantinou, P., Gastaldi-Ménager, C., Rachas, A., de Roquefeuil, L., Maura, G., Caillol, H., Tajahmady, A., Coste, J., Gissot, C., Weill, A., & Fagot-Campagna, A. (2017). Value of a national administrative database to guide public decisions : From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France. Revue d’Épidémiologie et de Santé Publique, 65, S149‑S167. https://doi.org/10.1016/j.respe.2017.05.004

2016

1. Annequin, M., Lert, F., Spire, B., Dray-Spira, R., & and the ANRS-Vespa2 Study Group. (2016). Increase in Unemployment over the 2000’s : Comparison between People Living with HIV and the French General Population. PloS One, 11(11), e0165634. https://doi.org/10.1371/journal.pone.0165634
2. Bannay, A., Chaignot, C., Blotière, P.-O., Basson, M., Weill, A., Ricordeau, P., & Alla, F. (2016). The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality. Medical Care, 54(2), 188‑194. https://doi.org/10.1097/MLR.0000000000000471
3. Basson, M., Mezzarobba, M., Weill, A., Ricordeau, P., Allemand, H., Alla, F., & Carbonnel, F. (2016). Severe intestinal malabsorption associated with olmesartan : A French nationwide observational cohort study. Gut, 65(10), 1664‑1669. https://doi.org/10.1136/gutjnl-2015-309690
4. Beziz, D., Colas, S., Collin, C., Dray-Spira, R., & Zureik, M. (2016). Association between Exposure to Benzodiazepines and Related Drugs and Survivorship of Total Hip Replacement in Arthritis : A Population-Based Cohort Study of 246,940 Patients. PLoS One, 11(5), e0155783. https://doi.org/10.1371/journal.pone.0155783
5. Blotière, P.-O., Rudant, J., Barré, A., Racine, A., Weill, A., Peyrin-Biroulet, L., Carbonnel, F., & Alla, F. (2016). Conditions of prescription of anti-TNF agents in newly treated patients with inflammatory bowel disease in France (2011-2013). Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 48(6), 620‑625. https://doi.org/10.1016/j.dld.2016.02.022
6. Bouillon, K., Bertrand, M., Boudali, L., Ducimetiere, P., Dray-Spira, R., & Zureik, M. (2016). Short-Term Risk of Bleeding During Heparin Bridging at Initiation of Vitamin K Antagonist Therapy in More Than 90 000 Patients With Nonvalvular Atrial Fibrillation Managed in Outpatient Care. J Am Heart Assoc, 5(11). https://doi.org/10.1161/JAHA.116.004065
7. Boyer, V., Vilotitch, A., Panjo, H., Sagaon-Teyssier, L., Marcellin, F., Dray-Spira, R., Spire, B., & Bajos, N. (2016). Heterosexual practices of women and men living with HIV attending hospital outpatient services (ANRS-VESPA2 survey) : A French comparative study with the general population (CSF survey). AIDS Care, 28(11), 1345‑1354. https://doi.org/10.1080/09540121.2016.1191600
8. Constantinou, P., Dray-Spira, R., & Menvielle, G. (2016). Cervical and breast cancer screening participation for women with chronic conditions in France : Results from a national health survey. BMC Cancer, 16, 255. https://doi.org/10.1186/s12885-016-2295-0
9. D’Almeida, K. W., Lert, F., Spire, B., & Dray-Spira, R. (2016). Determinants of virological response to antiretroviral therapy : Socio-economic status still plays a role in the era of cART. Results from the ANRS-VESPA 2 study, France. Antiviral Therapy, 21(8), 661‑670. https://doi.org/10.3851/IMP3064
10. de Monteynard, L.-A., Matheron, S., Gilquin, J., Pavie, J., de Truchis, P., Grabar, S., Launay, O., Meynard, J.-L., Khuong-Josses, M.-A., Rey, D., Simon, A., Mahamat, A., Dray-Spira, R., Costagliola, D., Abgrall, S., & FHDH-ANRS CO4. (2016). Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France. AIDS (London, England), 30(14), 2235‑2246. https://doi.org/10.1097/QAD.0000000000001193

11. Desgrees-du-Lou, A., Pannetier, J., Ravalihasy, A., Le Guen, M., Gosselin, A., Panjo, H., Bajos, N., Lydie, N., Lert, F., Dray-Spira, R., & PARCOURS Study Group. (2016). Is hardship during migration a determinant of HIV infection? Results from the ANRS PARCOURS study of sub-Saharan African migrants in France. AIDS (London, England), 30(4), 645‑656. https://doi.org/10.1097/QAD.0000000000000957
12. Ervasti, J., Kivimäki, M., Dray-Spira, R., Head, J., Goldberg, M., Pentti, J., Jokela, M., Vahtera, J., Zins, M., & Virtanen, M. (2016). Psychosocial factors associated with work disability in men and women with diabetes : A pooled analysis of three occupational cohort studies. Diabetic Medicine: A Journal of the British Diabetic Association, 33(2), 208‑217. https://doi.org/10.1111/dme.12821
13. Ervasti, Jenni, Kivimäki, M., Dray-Spira, R., Head, J., Goldberg, M., Pentti, J., Jokela, M., Vahtera, J., Zins, M., & Virtanen, M. (2016a). Comorbidity and work disability among employees with diabetes : Associations with risk factors in a pooled analysis of three cohort studies. Scandinavian Journal of Public Health, 44(1), 84‑90. https://doi.org/10.1177/1403494815605245
14. Ervasti, Jenni, Kivimäki, M., Dray-Spira, R., Head, J., Goldberg, M., Pentti, J., Jokela, M., Vahtera, J., Zins, M., & Virtanen, M. (2016b). Socioeconomic gradient in work disability in diabetes : Evidence from three occupational cohorts. Journal of Epidemiology and Community Health, 70(2), 125‑131. https://doi.org/10.1136/jech-2015-205943
15. Jean, K., Boily, M.-C., Danel, C., Moh, R., Badjé, A., Desgrées-du-Loû, A., Eholié, S., Lert, F., Dray-Spira, R., Anglaret, X., & Ouattara, E. (2016). What Level of Risk Compensation Would Offset the Preventive Effect of Early Antiretroviral Therapy? Simulations From the TEMPRANO Trial. American Journal of Epidemiology, 184(10), 755‑760. https://doi.org/10.1093/aje/kww127
16. Jean, K., Niangoran, S., Danel, C., Moh, R., Kouamé, G. M., Badjé, A., Gabillard, D., Eholié, S., Dray-Spira, R., Lert, F., Anglaret, X., & Desgrées-Du-LoÛ, A. (2016). Early antiretroviral therapy initiation in west Africa has no adverse social consequences : A 24-month prospective study. AIDS (London, England), 30(10), 1677‑1682. https://doi.org/10.1097/QAD.0000000000001100
17. Neumann, A., & Billionnet, C. (2016). Covariate adjustment of cumulative incidence functions for competing risks data using inverse probability of treatment weighting. Computer Methods and Programs in Biomedicine, 129, 63‑70. https://doi.org/10.1016/j.cmpb.2016.03.008
18. Plazy, M., Farouki, K. E., Iwuji, C., Okesola, N., Orne-Gliemann, J., Larmarange, J., Lert, F., Newell, M.-L., Dabis, F., Dray-Spira, R., & Anrs 12249 Tasp Study Group. (2016). Access to HIV care in the context of universal test and treat : Challenges within the ANRS 12249 TasP cluster-randomized trial in rural South Africa. Journal of the International AIDS Society, 19(1), 20913. https://doi.org/10.7448/IAS.19.1.20913
19. Quantin, C., Roussot, A., Besson, J., Cottenet, J., Bismuth, M.-J., Cousin, F., Soudry-Faure, A., Mariet, A.-S., & Collin, C. (2016). Étude des algorithmes de repérage de la dépression dans le SNIIRAM par le réseau REDSIAM. Revue francaise des affaires sociales, 2, 201‑225.
20. Raguideau, F., Dray-Spira, R., & Zureik, M. (2016). Oral Fluoroquinolone Use and Retinal Detachment-Reply. JAMA Ophthalmol, 134(12), 1448‑1449. https://doi.org/10.1001/jamaophthalmol.2016.3479
21. Raguideau, F., Lemaitre, M., Dray-Spira, R., & Zureik, M. (2016). Association Between Oral Fluoroquinolone Use and Retinal Detachment. JAMA Ophthalmol, 134(4), 415‑421. https://doi.org/10.1001/jamaophthalmol.2015.6205

22. Sagaon-Teyssier, L., Fressard, L., Mora, M., Maradan, G., Guagliardo, V., Suzan-Monti, M., Dray-Spira, R., Spire, B., & VESPA2 Study Group. (2016). Larger is not necessarily better! Impact of HIV care unit characteristics on virological success : Results from the French national representative ANRS-VESPA2 study. Health Policy (Amsterdam, Netherlands), 120(8), 936‑947. https://doi.org/10.1016/j.healthpol.2016.07.003
23. Supervie, V., Marty, L., Lacombe, J.-M., Dray-Spira, R., Costagliola, D., & FHDH-ANRS CO4 study group. (2016). Looking Beyond the Cascade of HIV Care to End the AIDS Epidemic : Estimation of the Time Interval From HIV Infection to Viral Suppression. Journal of Acquired Immune Deficiency Syndromes (1999), 73(3), 348‑355. https://doi.org/10.1097/QAI.0000000000001120
24. Suzan-Monti, M., Lorente, N., Demoulin, B., Marcellin, F., Préau, M., Dray-Spira, R., Lert, F., Spire, B., & ANRS-VESPA2 Study Group. (2016). Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission : Results from the ANRS-VESPA2 survey. Journal of the International AIDS Society, 19(1), 20095. https://doi.org/10.7448/IAS.19.1.20095
25. Suzan-Monti, M., Sagaon-Teyssier, L., Demoulin, B., Vilotitch, A., Préau, M., Dray-Spira, R., Lert, F., & Spire, B. (2016). Sexual Behavior with Serodiscordant Partners Among HIV-Positive Men Who Have Sex with Men Followed Up in Hospitals Between 2003 and 2011 in France : Results from a Repeated National Representative Survey (ANRS VESPA and VESPA2). AIDS Patient Care and STDs, 30(5), 193‑196. https://doi.org/10.1089/apc.2016.0015
26. Weill, A., Dalichampt, M., Raguideau, F., Ricordeau, P., Blotière, P.-O., Rudant, J., Alla, F., & Zureik, M. (2016). Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women : Cohort study. BMJ (Clinical Research Ed.), 353, i2002. https://doi.org/10.1136/bmj.i2002

2015

1. Annequin, M., Lert, F., Spire, B., Dray-Spira, R., & VESPA2 Study Group. (2015). Has the employment status of people living with HIV changed since the early 2000s? AIDS (London, England), 29(12), 1537‑1547. https://doi.org/10.1097/QAD.0000000000000722
2. Annequin, M., Weill, A., Thomas, F., & Chaix, B. (2015). Environmental and individual characteristics associated with depressive disorders and mental health care use. Annals of Epidemiology, 25(8), 605‑612. https://doi.org/10.1016/j.annepidem.2015.02.002
3. Bouillon, K., Bertrand, M., Maura, G., Blotière, P.-O., Ricordeau, P., & Zureik, M. (2015). Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant : A retrospective, matched-cohort study. The Lancet. Haematology, 2(4), e150-159. https://doi.org/10.1016/S2352-3026(15)00027-7
4. Carcaillon, L., Plichart, M., Zureik, M., Rouaud, O., Majed, B., Ritchie, K., Tzourio, C., Dartigues, J.-F., & Empana, J.-P. (2015). Carotid plaque as a predictor of dementia in older adults : The Three-City Study. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 11(3), 239‑248. https://doi.org/10.1016/j.jalz.2014.07.160
5. Chaignot, C., Weill, A., Ricordeau, P., & Alla, F. (2015). [Use in France of Baclofen for Alcohol Dependence from 2007 to 2013 : Cohort Study Based on the Databases SNIIRAM and PMSI]. Therapie, 70(5), 443‑453. https://doi.org/10.2515/therapie/2015027
6. Colas, S., Collin, C., Piriou, P., & Zureik, M. (2015). Association Between Total Hip Replacement Characteristics and 3-Year Prosthetic Survivorship : A Population-Based Study. JAMA Surg, 150(10), 979‑988. https://doi.org/10.1001/jamasurg.2015.1325
7. de Monteynard, L.-A., Dray-Spira, R., de Truchis, P., Grabar, S., Launay, O., Meynard, J.-L., Khuong-Josses, M.-A., Gilquin, J., Rey, D., Simon, A., Pavie, J., Mahamat, A., Matheron, S., Costagliola, D., Abgrall, S., & French Hospital Database on HIV. (2015). Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France. PloS One, 10(3), e0118492. https://doi.org/10.1371/journal.pone.0118492
8. Desgrées-du-Loû, A., Pannetier, J., Ravalihasy, A., Gosselin, A., Supervie, V., Panjo, H., Bajos, N., Lert, F., Lydié, N., Dray-Spira, R., & Parcours Study Group5. (2015). Sub-Saharan African migrants living with HIV acquired after migration, France, ANRS PARCOURS study, 2012 to 2013. Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 20(46). https://doi.org/10.2807/1560-7917.ES.2015.20.46.30065
9. Lemaitre, M., Lastennet, G., Syr, D., Emmerich, J., & Zureik, M. (2015). Impact of the 2013 French Pill Crisis on Women’s Behaviour Regarding Contraception. Drugs Real World Outcomes, 2(1), 13‑22. https://doi.org/10.1007/s40801-015-0011-z
10. Maraux, B., Hamelin, C., Bajos, N., Dray-Spira, R., Spire, B., Lert, F., & Vespa2 study group. (2015). Women living with HIV still lack highly effective contraception : Results from the ANRS VESPA2 study, France, 2011. Contraception, 92(2), 160‑169. https://doi.org/10.1016/j.contraception.2015.04.010
11. Marcellin, F., Demoulin, B., Spire, B., Suzan-Monti, M., Roux, P., Protopopescu, C., Sagaon-Teyssier, L., Duracinsky, M., Dray-Spira, R., Carrieri, M. P., & ANRS-VESPA2 Study Group. (2015). Spontaneous and post-treatment HCV clearance : Relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study). Expert Review of Gastroenterology & Hepatology, 9(5), 701‑713. https://doi.org/10.1586/17474124.2015.1016914
12. Marcellin, F., Demoulin, B., Suzan-Monti, M., Maradan, G., Carrieri, M. P., Dray-Spira, R., Spire, B., & ANRS-VESPA2 Study Group. (2015). Risk Factors for HCV Reinfection or Transmission in HIV-HCV Coinfected MSM (ANRS-VESPA2 French National Survey). Journal of Acquired Immune Deficiency Syndromes (1999), 70(5), e179-182. https://doi.org/10.1097/QAI.0000000000000836
13. Massari, V., Lapostolle, A., Grupposo, M.-C., Dray-Spira, R., Costagliola, D., & Chauvin, P. (2015). Which adults in the Paris metropolitan area have never been tested for HIV? A 2010 multilevel, cross-sectional, population-based study. BMC Infectious Diseases, 15, 278. https://doi.org/10.1186/s12879-015-1006-9
14. Maura, G., Blotiere, P.-O., Bouillon, K., Billionnet, C., Ricordeau, P., Alla, F., & Zureik, M. (2015). Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists : A French nationwide propensity-matched cohort study. Circulation, 132(13), 1252‑1260. https://doi.org/10.1161/CIRCULATIONAHA.115.015710
15. Migrants Working Group on behalf of COHERE in EuroCoord. (2015). Mortality in migrants living with HIV in western Europe (1997-2013) : A collaborative cohort study. The Lancet. HIV, 2(12), e540-549. https://doi.org/10.1016/S2352-3018(15)00203-9
16. Orne-Gliemann, J., Larmarange, J., Boyer, S., Iwuji, C., McGrath, N., Bärnighausen, T., Zuma, T., Dray-Spira, R., Spire, B., Rochat, T., Lert, F., Imrie, J., & ANRS 12249 TasP Group. (2015). Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa : Methods for appraisal. BMC Public Health, 15, 209. https://doi.org/10.1186/s12889-015-1344-y
17. Plazy, M., Newell, M.-L., Orne-Gliemann, J., Naidu, K., Dabis, F., & Dray-Spira, R. (2015). Barriers to antiretroviral treatment initiation in rural KwaZulu-Natal, South Africa. HIV Medicine, 16(9), 521‑532. https://doi.org/10.1111/hiv.12253
18. Plazy, Mélanie, Dabis, F., Naidu, K., Orne-Gliemann, J., Barnighausen, T., & Dray-Spira, R. (2015). Change of treatment guidelines and evolution of ART initiation in rural South Africa : Data of a large HIV care and treatment programme. BMC Infectious Diseases, 15, 452. https://doi.org/10.1186/s12879-015-1207-2
19. Plazy, Mélanie, Orne-Gliemann, J., Dabis, F., & Dray-Spira, R. (2015). Retention in care prior to antiretroviral treatment eligibility in sub-Saharan Africa : A systematic review of the literature. BMJ Open, 5(6), e006927. https://doi.org/10.1136/bmjopen-2014-006927
20. Raguideau, F., Mezzarobba, M., Zureik, M., Weill, A., Ricordeau, P., & Alla, F. (2015). Compliance with pregnancy prevention plan recommendations in 8672 French women of childbearing potential exposed to acitretin. Pharmacoepidemiology and Drug Safety, 24(5), 526‑533. https://doi.org/10.1002/pds.3763
21. Roussel, R., Chaignot, C., Weill, A., Travert, F., Hansel, B., Marre, M., Ricordeau, P., Alla, F., & Allemand, H. (2015). Use of Fibrates Monotherapy in People with Diabetes and High Cardiovascular Risk in Primary Care : A French Nationwide Cohort Study Based on National Administrative Databases. PloS One, 10(9), e0137733. https://doi.org/10.1371/journal.pone.0137733
22. Tricotel, A., Collin, C., & Zureik, M. (2015). Impact of the sharp changes in the use of contraception in 2013 on the risk of pulmonary embolism in France. J Thromb Haemost, 13(9), 1576‑1580. https://doi.org/10.1111/jth.13053
23. Virtanen, M., Kivimäki, M., Zins, M., Dray-Spira, R., Oksanen, T., Ferrie, J. E., Okuloff, A., Pentti, J., Head, J., Goldberg, M., & Vahtera, J. (2015). Lifestyle-related risk factors and trajectories of work disability over 5 years in employees with diabetes : Findings from two prospective cohort studies. Diabetic Medicine: A Journal of the British Diabetic Association, 32(10), 1335‑1341. https://doi.org/10.1111/dme.12787
24. Virtanen, Marianna, Vahtera, J., Head, J., Dray-Spira, R., Okuloff, A., Tabak, A. G., Goldberg, M., Ervasti, J., Jokela, M., Singh-Manoux, A., Pentti, J., Zins, M., & Kivimäki, M. (2015). Work Disability among Employees with Diabetes : Latent Class Analysis of Risk Factors in Three Prospective Cohort Studies. PloS One, 10(11), e0143184. https://doi.org/10.1371/journal.pone.0143184

2014
1. Blotière, P.-O., Weill, A., Ricordeau, P., Alla, F., & Allemand, H. (2014). Perforations and haemorrhages after colonoscopy in 2010 : A study based on comprehensive French health insurance data (SNIIRAM). Clinics and Research in Hepatology and Gastroenterology, 38(1), 112‑117. https://doi.org/10.1016/j.clinre.2013.10.005
2. Brondeel, R., Weill, A., Thomas, F., & Chaix, B. (2014). Use of healthcare services in the residence and workplace neighbourhood : The effect of spatial accessibility to healthcare services. Health & Place, 30, 127‑133. https://doi.org/10.1016/j.healthplace.2014.09.004
3. Douab, T., Marcellin, F., Vilotitch, A., Protopopescu, C., Préau, M., Suzan-Monti, M., Sagaon-Teyssier, L., Lert, F., Carrieri, M. P., Dray-Spira, R., Spire, B., & ANRS-VESPA2 Study Group. (2014). Health-related quality of life of people living with HIV followed up in hospitals in France : Comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys). AIDS Care, 26 Suppl 1, S29-40. https://doi.org/10.1080/09540121.2014.906553
4. Emmerich, J., Thomassin, C., & Zureik, M. (2014). Contraceptive pills and thrombosis : Effects of the French crisis on prescriptions and consequences for medicine agencies. Journal of Thrombosis and Haemostasis: JTH, 12(9), 1388‑1390. https://doi.org/10.1111/jth.12661
5. Fromont, A., Lehanneur, M.-N., Rollot, F., Weill, A., Clerc, L., Bonithon Kopp, C., Binquet, C., & Moreau, T. (2014). [Cost of multiple sclerosis in France]. Revue Neurologique, 170(6‑7), 432‑439. https://doi.org/10.1016/j.neurol.2014.02.007
6. Jean, K., Gabillard, D., Moh, R., Danel, C., Desgrées-du-Loû, A., N’takpe, J.-B., Le Carrou, J., Badjé, A., Eholié, S., Lert, F., Anglaret, X., & Dray-Spira, R. (2014). Decrease in sexual risk behaviours after early initiation of antiretroviral therapy : A 24-month prospective study in Côte d’Ivoire. Journal of the International AIDS Society, 17, 18977. https://doi.org/10.7448/IAS.17.1.18977
7. Jean, K., Gabillard, D., Moh, R., Danel, C., Fassassi, R., Desgrées-du-Loû, A., Eholié, S., Lert, F., Anglaret, X., & Dray-Spira, R. (2014). Effect of early antiretroviral therapy on sexual behaviors and HIV-1 transmission risk among adults with diverse heterosexual partnership statuses in Côte d’Ivoire. The Journal of Infectious Diseases, 209(3), 431‑440. https://doi.org/10.1093/infdis/jit470
8. Lalanne, C., Duracinsky, M., Marcellin, F., Lert, F., Chassany, O., Carrieri, P. M., Dray-Spira, R., & Spire, B. (2014). Confirmation of the Factor Structure of the Proqol-HIV Questionnaire to Assess Health-Related Quality of Life in PLWHA. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A681-682. https://doi.org/10.1016/j.jval.2014.08.2542
9. Marsicano, E., Dray-Spira, R., Lert, F., Aubrière, C., Spire, B., Hamelin, C., & ANRS-Vespa2 study group. (2014). Multiple discriminations experienced by people living with HIV in France : Results from the ANRS-Vespa2 study. AIDS Care, 26 Suppl 1, S97‑S106. https://doi.org/10.1080/09540121.2014.907385
10. Menvielle, G., Richard, J.-B., Ringa, V., Dray-Spira, R., & Beck, F. (2014). To what extent is women’s economic situation associated with cancer screening uptake when nationwide screening exists? A study of breast and cervical cancer screening in France in 2010. Cancer Causes & Control: CCC, 25(8), 977‑983. https://doi.org/10.1007/s10552-014-0397-z
11. Neumann, A., Maura, G., Weill, A., Ricordeau, P., Alla, F., & Allemand, H. (2014). Comparative effectiveness of rosuvastatin versus simvastatin in primary prevention among new users : A cohort study in the French national health insurance database. Pharmacoepidemiology and Drug Safety, 23(3), 240‑250. https://doi.org/10.1002/pds.3544
12. Plazy, M., Dray-Spira, R., Orne-Gliemann, J., Dabis, F., & Newell, M.-L. (2014). Continuum in HIV care from entry to ART initiation in rural KwaZulu-Natal, South Africa. Tropical Medicine & International Health: TM & IH, 19(6), 680‑689. https://doi.org/10.1111/tmi.12301
13. Racine, A., Cuerq, A., Bijon, A., Ricordeau, P., Weill, A., Allemand, H., Chosidow, O., Boutron-Ruault, M.-C., & Carbonnel, F. (2014). Isotretinoin and risk of inflammatory bowel disease : A French nationwide study. The American Journal of Gastroenterology, 109(4), 563‑569. https://doi.org/10.1038/ajg.2014.8
14. Roche, N., Chavaillon, J.-M., Maurer, C., Zureik, M., & Piquet, J. (2014). A clinical in-hospital prognostic score for acute exacerbations of COPD. Respiratory Research, 15, 99. https://doi.org/10.1186/s12931-014-0099-9
15. Romon, I., Rey, G., Mandereau-Bruno, L., Weill, A., Jougla, E., Eschwège, E., Simon, D., Druet, C., & Fagot-Campagna, A. (2014). The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes—The 2001-2006 ENTRED cohort. Diabetic Medicine: A Journal of the British Diabetic Association, 31(8), 946‑953. https://doi.org/10.1111/dme.12435
16. Socio-economic Inequalities and HIV Writing Group for Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord, Lodi, S., Dray-Spira, R., Touloumi, G., Braun, D., Teira, R., D’Arminio Monforte, A., Gallois, A., Zangerle, R., Spire, B., Dabis, F., Stähelin, C., Termote, M., Kirk, O., Chêne, G., Egger, M., & del Amo, J. (2014). Delayed HIV diagnosis and initiation of antiretroviral therapy : Inequalities by educational level, COHERE in EuroCoord. AIDS (London, England), 28(15), 2297‑2306. https://doi.org/10.1097/QAD.0000000000000410
17. Tricotel, A., Raguideau, F., Collin, C., & Zureik, M. (2014). Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France. PLoS One, 9(4), e93792. https://doi.org/10.1371/journal.pone.0093792
18. Tron, L., Lert, F., Spire, B., Dray-Spira, R., & ANRS-Vespa2 study group. (2014). Tobacco smoking in HIV-infected versus general population in france : Heterogeneity across the various groups of people living with HIV. PloS One, 9(9), e107451. https://doi.org/10.1371/journal.pone.0107451
19. Wilson, K. d’Almeida, Dray-Spira, R., Aubrière, C., Hamelin, C., Spire, B., Lert, F., & ANRS-Vespa2 Study Group. (2014). Frequency and correlates of late presentation for HIV infection in France : Older adults are a risk group – results from the ANRS-VESPA2 Study, France. AIDS Care, 26 Suppl 1, S83-93. https://doi.org/10.1080/09540121.2014.906554

2013
1. Assogba, F. A., Penformis, F., Detournay, B., Lecomte, P., Bourdel-Marchasson, I., Druet, C., Weill, A., Fagot-Campagna, A., & Fosse-Edorh, S. (2013). Facteurs associés à l’hospitalisation des personnes diabétiques adultes en France. Entred 2007. Bulletin Epidémiologique Hebdomadaire, 37‑38, 454‑463.
2. Brisset, M., Boutouyrie, P., Pico, F., Zhu, Y., Zureik, M., Schilling, S., Dufouil, C., Mazoyer, B., Laurent, S., Tzourio, C., & Debette, S. (2013). Large-vessel correlates of cerebral small-vessel disease. Neurology, 80(7), 662‑669. https://doi.org/10.1212/WNL.0b013e318281ccc2
3. Dray-Spira, R. (2013). [Chronic diseases and employment : Impact on social health inequalities]. Revue D’epidemiologie Et De Sante Publique, 61 Suppl 3, S146-151. https://doi.org/10.1016/j.respe.2013.04.002
4. Dray-Spira, R., Herquelot, E., Bonenfant, S., Guéguen, A., & Melchior, M. (2013). Impact of diabetes mellitus onset on sickness absence from work—A 15-year follow-up of the GAZEL Occupational Cohort Study. Diabetic Medicine: A Journal of the British Diabetic Association, 30(5), 549‑556. https://doi.org/10.1111/dme.12076
5. Druet, C., Bourdel-Marchasson, I., Weill, A., Eschwege, E., Penfornis, A., Fosse, S., Fournier, C., Chantry, M., Attali, C., Lecomte, P., Simon, D., Poutignat, N., Gautier, A., Risse, M., & Fagot-Campagna, A. (2013). Le diabète de type 2 en France : Épidémiologie, évolution de la qualité de la prise en charge, poids social et économique. Entred 2007. La Presse Médicale, 42(5), 830‑838. https://doi.org/10.1016/j.lpm.2013.02.312
6. Fagot, J.-P., Blotière, P.-O., Ricordeau, P., Weill, A., Alla, F., & Allemand, H. (2013). Does Insulin Glargine Increase the Risk of Cancer Compared With Other Basal Insulins? Diabetes Care, 36(2), 294‑301. https://doi.org/10.2337/dc12-0506
7. Fromont, A., Binquet, C., Rollot, F., Despalins, R., Weill, A., Clerc, L., Bonithon-Kopp, C., & Moreau, T. (2013). Comorbidities at multiple sclerosis diagnosis. Journal of Neurology, 260(10), 2629‑2637. https://doi.org/10.1007/s00415-013-7041-9
8. Grimaldi-Bensouda, L., Zureik, M., Aubier, M., Humbert, M., Levy, J., Benichou, J., Molimard, M., Abenhaim, L., & Pharmacoepidemiology of Asthma and Xolair (PAX) Study Group. (2013). Does omalizumab make a difference to the real-life treatment of asthma exacerbations? : Results from a large cohort of patients with severe uncontrolled asthma. Chest, 143(2), 398‑405. https://doi.org/10.1378/chest.12-1372
9. Kudjawu, Y., de Maria, F., Decool, E., Altana, M., Harlin, J.-M., Weill, A., Nicolau, J., Leroy, C., & Grémy, I. (2013). Croisement de deux bases de données médico-administratives : Méthodologie et étude descriptive pour une application à la surveillance épidémiologique des cancers en France. Bulletin Epidémiologique Hebdomadaire, Hors-série, 49‑58.
10. Legeai, C., Vigouroux, C., Souberbielle, J.-C., Bouchaud, O., Boufassa, F., Bastard, J.-P., Carlier, R., Capeau, J., Goujard, C., Meyer, L., Viard, J.-P., & ANRS-COPANA Cohort Study Group. (2013). Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons : The ANRS CO9 «COPANA» cohort study. PloS One, 8(9), e74868. https://doi.org/10.1371/journal.pone.0074868
11. Neumann, A., Weill, A., Ricordeau, P., Fagot, J.-P., Alla, F., & Allemand, H. (2013). Pioglitazone and risk of bladder cancer : Clarification of the design of the French study. Reply to Perez AT [letter]. Diabetologia, 56(1), 228‑229. https://doi.org/10.1007/s00125-012-2769-9
12. Uhry, Z., Remontet, L., Colonna, M., Belot, A., Grosclaude, P., Mitton, N., Delacour-Billon, S., Gentil, J., Boussac-Zarebska, M., Bossard, N., Danzon, A., Altana, M., Frete, F., Weill, A., & Rogel, A. (2013). Cancer incidence estimation at a district level without a national registry : A validation study for 24 cancer sites using French health insurance and registry data. Cancer Epidemiology, 37(2), 99‑114. https://doi.org/10.1016/j.canep.2012.10.010